Paper12880
Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.
Mehta J and 1 other. Circulation, 1977. Cited by 115 papers, by iCite.
Cite this record
ConductScience Library. Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects. Papers, record 12880. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12880
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adrenergic alpha-Antagonists | Major topic |
| Adrenergic beta-Antagonists | Major topic |
| Ethanolamines | Major topic |
| Hemodynamics | Major topic |
| Hypertension | Major topic |
| Labetalol | Major topic |
| Adult | |
| Amyl Nitrite | |
| Blood Pressure | |
| Cardiac Output | |
| Clinical Trials as Topic | |
| Dose-Response Relationship, Drug | |
| Heart Rate | |
| Humans | |
| Isoproterenol | |
| Male | |
| Middle Aged | |
| Phenylephrine | |
| Physical Exertion | |
| Renin | |
| Valsalva Maneuver | |
| Vascular Resistance |
Source PubMed
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 115 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32709242 | Retrospective evaluation of labetalol as antihypertensive agent in dogs. | BMC Vet Res | 2020 | https://conductscience.org/library/papers/32709242 | PubMed |
| 27042322 | Maternal ethnicity and its impact on the haemodynamic and blood pressure response to labetalol for the treatment of antenatal hypertension. | Open Heart | 2016 | https://conductscience.org/library/papers/27042322 | PubMed |
| 7428793 | Comparison of the effects of propranolol and labetalol on renal haemodynamics at rest and during exercise in essential hypertension. | Eur J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7428793 | PubMed |
| 7374093 | Effects of chronic alpha and beta adrenoceptor blockade with labetalol on plasma catecholamines and renal function in hypertension. | Klin Wochenschr | 1980 | https://conductscience.org/library/papers/7374093 | PubMed |
| 7371699 | Acute and long-term effects of labetalol on systemic and pulmonary haemodynamics in hypertensive patients. | Eur J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7371699 | PubMed |
| 7308279 | The electrophysiological effects of intravenous labetalol in man. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7308279 | PubMed |
| 7093104 | The acute and chronic hypotensive effect of labetalol and the relationship with pretreatment plasma noradrenaline levels. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7093104 | PubMed |
| 7093099 | A review of the haemodynamic effects of labetalol in man. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7093099 | PubMed |
| 7093094 | Alternatives to beta-blockade in therapy of hypertension with angina pectoris: role of nifedipine or of labetalol. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7093094 | PubMed |
| 7093092 | Effects of combined alpha- and beta-blockade by labetalol in patients with coronary artery disease. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7093092 | PubMed |
| 7082539 | Rapid reduction of blood pressure with acute oral labetalol. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7082539 | PubMed |
| 7046773 | Response of the systemic pulmonary circulation to labetalol at rest and during exercise. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7046773 | PubMed |
| 6511284 | Labetolol in patients with hypertension and varying degrees of renal impairment. | Ir J Med Sci | 1984 | https://conductscience.org/library/papers/6511284 | PubMed |
| 6386022 | Effect of indoramin, labetalol and alinidine on sympathetic function in normal man. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6386022 | PubMed |
| 6370541 | Clinical pharmacokinetics of labetalol. | Clin Pharmacokinet | 1984 | https://conductscience.org/library/papers/6370541 | PubMed |
| 6310204 | Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension. | Klin Wochenschr | 1983 | https://conductscience.org/library/papers/6310204 | PubMed |
| 6151890 | Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol. | Drugs | 1984 | https://conductscience.org/library/papers/6151890 | PubMed |
| 6151889 | Pharmacology of combined alpha-beta-blockade. I. | Drugs | 1984 | https://conductscience.org/library/papers/6151889 | PubMed |
| 6127131 | The alpha- and beta-adrenoceptor blocking potencies of labetalol and its individual stereoisomers in anaesthetized dogs and in isolated tissues. | Br J Pharmacol | 1982 | https://conductscience.org/library/papers/6127131 | PubMed |
| 6124265 | Comparison of labetalol with other anti-hypertensive drugs. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6124265 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12880
GET https://conductscience.org/api/papers/v1/12880/cited_by?page=2